Inovio Biomedical Corporation (AMEX: INO) announced today that Mark L. Bagarazzi, M.D., has been appointed Chief Medical Officer. Dr. Bagarazzi ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE